Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

被引：306

作者：

Bergenstal, Richard M. ^{[1
]}

Rosenstock, Julio ^{[2
]}

Arakaki, Richard F. ^{[3
]}

Prince, Melvin J. ^{[4
]}

Qu, Yongming ^{[4
]}

Sinha, Vikram P. ^{[4
]}

Howey, Daniel C. ^{[4
]}

Jacober, Scott J. ^{[4
]}

机构：

[1] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA

[2] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX USA

[3] Univ Hawaii Manoa, Honolulu, HI 96822 USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

DIABETES CARE | 2013年 / 36卷 / 07期

关键词：

D O I：

10.2337/dc13-0295

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E107 / +

页数：2

共 3 条

[1] A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes [J].

Bergenstal, Richard M. ;

Rosenstock, Julio ;

Arakaki, Richard F. ;

Prince, Melvin J. ;

Qu, Yongming ;

Sinha, Vikram P. ;

Howey, Daniel C. ;

Jacober, Scott J. .

DIABETES CARE, 2012, 35 (11) :2140-2147

[2] Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients with type 2 Diabetes. Diabetes Care 2012;35:2140-2147 [J].

Home, Philip D. .

DIABETES CARE, 2013, 36 (07) :E106-E106

[3] Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes A randomized, crossover study [J].

Rosenstock, Julio ;

Bergenstal, Richard M. ;

Blevins, Thomas C. ;

Morrow, Linda A. ;

Prince, Melvin J. ;

Qu, Yongming ;

Sinha, Vikram P. ;

Howey, Daniel C. ;

Jacober, Scott J. .

DIABETES CARE, 2013, 36 (03) :522-528

← 1 →